Correlation Between Codiak BioSciences and Viking Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Codiak BioSciences and Viking Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Codiak BioSciences and Viking Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Codiak BioSciences and Viking Therapeutics, you can compare the effects of market volatilities on Codiak BioSciences and Viking Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Codiak BioSciences with a short position of Viking Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Codiak BioSciences and Viking Therapeutics.

Diversification Opportunities for Codiak BioSciences and Viking Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Codiak and Viking is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Codiak BioSciences and Viking Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viking Therapeutics and Codiak BioSciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Codiak BioSciences are associated (or correlated) with Viking Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viking Therapeutics has no effect on the direction of Codiak BioSciences i.e., Codiak BioSciences and Viking Therapeutics go up and down completely randomly.

Pair Corralation between Codiak BioSciences and Viking Therapeutics

If you would invest  1,053  in Viking Therapeutics on November 1, 2024 and sell it today you would earn a total of  2,316  from holding Viking Therapeutics or generate 219.94% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Codiak BioSciences  vs.  Viking Therapeutics

 Performance 
       Timeline  
Codiak BioSciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Codiak BioSciences has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable forward-looking signals, Codiak BioSciences is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.
Viking Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Viking Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Codiak BioSciences and Viking Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Codiak BioSciences and Viking Therapeutics

The main advantage of trading using opposite Codiak BioSciences and Viking Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Codiak BioSciences position performs unexpectedly, Viking Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viking Therapeutics will offset losses from the drop in Viking Therapeutics' long position.
The idea behind Codiak BioSciences and Viking Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Content Syndication
Quickly integrate customizable finance content to your own investment portal